Contineum Therapeutics In... (CTNM)
Contineum Therapeutics Class A Common Stock Max Pain By Strike
CTNM trades at $11.5, 53.3% above the near-term max pain of $7.5 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($2.5-$10), reflecting growing call interest at higher strikes. Key magnetic zone at 3 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Contineum Therapeutics Class A Common Stock Max Pain By Expiry
Max pain for CTNM shows an upward trend from 2.5 to 10, suggesting bullish positioning in longer-dated options. The 133% spread signals divergent expectations across timeframes. Most levels below 11.5 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Oct 17, 2025 | 7.5 | n/a (n/a) |
| Nov 21, 2025 | 10 | n/a (n/a) |
| Jan 16, 2026 | 2.5 | n/a (n/a) |
| Apr 17, 2026 | 2.5 | n/a (n/a) |